Management of left ventricular thrombus: diagnostic 
and therapeutic methods: a review article

Mehrpooya, Maryam; Sadeghi, Zahra

Volume 81, Issue 8 (November 2023) Tehran Univ Med J 2023, 81(8): 559-564 | Back to browse issues page

Mendeley

Zotero

RefWorks

Mehrpooya M, Sadeghi Z. Management of left ventricular thrombus: diagnostic and therapeutic methods: a review article. Tehran Univ Med J 2023; 81 (8) :559-564
URL: http://tumj.tums.ac.ir/article-1-12740-en.html

Management of left ventricular thrombus: diagnostic and therapeutic methods: a review article

Maryam Mehrpooya¹

, Zahra Sadeghi ^*

1- Department of Cardiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
2- Medical Student, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. , z-sadeghi@student.tums.ac.ir

Abstract: (468 Views)

Left ventricular thrombosis (LVT) is a very serious condition and life-threatening complication that usually occurs after acute occlusion of the left anterior descending (LAD) coronary artery followed by acute myocardial infarction with ST-segment elevation (STEMI), which leads to significant regional wall motion abnormality (RWMA). It should be noted that its diagnosis, treatment, and management are challenging now and depend on various factors such as the type of thrombus, time of percutaneous coronary intervention (PCI), and underlying disease. The preferred diagnostic method is cardiovascular magnetic resonance imaging (CMR), but transthoracic echocardiography (TTE) is routinely used for diagnostic and screening purposes also follow-up of response to treatment. It is worth mentioning that when the diagnosis of left ventricular thrombus is not clear with conventional echocardiography, contrast echocardiography is used for more resolution and detailed information. Left ventricular thrombosis can appear in both acute and chronic forms and lead to significant complications, the most important of them are stroke and systemic arterial embolism (SE). According to previous studies, vitamin K antagonist (warfarin) by keeping INR within the therapeutic range currently used to treat left ventricular thrombosis. Although the use of direct oral anticoagulants (DOAC) has brought excellent outcomes, but due to the lack of large clinical trials, the routine use of these agents is controversial, and only in case of warfarin intolerance or contraindications, DOACs can be used as an alternative. Generally, the best way to prevent left ventricular thrombosis is primary percutaneous coronary angioplasty (primary PCI) which preserves left ventricular function. Depending on the sensitivity of the diagnostic method, thrombus will likely resolve in >50% of patients by six months after the MI. On the other hand, in rare cases, surgery is indicated if a thrombosis remains despite the medical treatment especially if it is accompanied by a left ventricular aneurysm. The purpose of this narrative review is to evaluate the latest evidence in the field of left ventricular thrombosis management and to adopt the best approach for these patients.

Keywords: acute myocardial infarction, left ventricle, oral anticoagulants, thrombosis.

Full-Text [PDF 332 kb] (268 Downloads)

Type of Study: Review Article |